This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Starpharma Pty Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Clare Frances Price: Innovator in Bacterial Vaginosis Treatment
Introduction
Clare Frances Price is a notable inventor based in Elsternwick, Australia. She has made significant contributions to the field of medical treatments, particularly in the area of bacterial vaginosis. Her innovative approach has led to the development of a unique method aimed at preventing and alleviating the symptoms associated with this condition.
Latest Patents
Clare Frances Price holds a patent for a method of prophylaxis of bacterial vaginosis. This patent outlines methods for the treatment or prevention of bacterial vaginosis, focusing on the recurrence of the condition and the alleviation of its symptoms. The methods involve the administration of an effective amount of a macromolecule, which includes polylysine, polyamidoamine, poly(etherhydroxyamine), or poly(propyleneimine) dendrimers, along with one or more sulfonic acid-containing moieties attached to them.
Career Highlights
Clare is associated with Starpharma Pty Limited, where she continues to work on innovative solutions in the medical field. Her dedication to research and development has positioned her as a key figure in her area of expertise. With her patent, she has contributed to advancing treatment options for bacterial vaginosis, which affects many individuals worldwide.
Collaborations
Clare has collaborated with notable colleagues, including Jeremy Robert Arthur Paull and Jacinth Kincaid Fairley. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments.
Conclusion
Clare Frances Price is a pioneering inventor whose work in the treatment of bacterial vaginosis has made a significant impact. Her innovative methods and collaborations continue to advance the field of medical treatments, showcasing her commitment to improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile